APA (7th ed.) Citation

Erdem, J. S., Skaug, V., Bakke, P., Gulsvik, A., Haugen, A., Zienolddiny, S., & Samulin Erdem, J. (2016). Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer. BMC Cancer, 16, 1. https://doi.org/10.1186/s12885-016-2061-3

Chicago Style (17th ed.) Citation

Erdem, Johanna Samulin, Vidar Skaug, Per Bakke, Amund Gulsvik, Aage Haugen, Shanbeh Zienolddiny, and Johanna Samulin Erdem. "Mutations in TP53 Increase the Risk of SOX2 Copy Number Alterations and Silencing of TP53 Reduces SOX2 Expression in Non-small Cell Lung Cancer." BMC Cancer 16 (2016): 1. https://doi.org/10.1186/s12885-016-2061-3.

MLA (9th ed.) Citation

Erdem, Johanna Samulin, et al. "Mutations in TP53 Increase the Risk of SOX2 Copy Number Alterations and Silencing of TP53 Reduces SOX2 Expression in Non-small Cell Lung Cancer." BMC Cancer, vol. 16, 2016, p. 1, https://doi.org/10.1186/s12885-016-2061-3.